As pointed out previously, sensitivity and specificity define the discriminative power of a diagnostic procedure (test) and give us the proportion of diseased and healthy individuals identified correctly by the test, respectively.
the test in order to update the pre-test probability of a disease in a certain patient 
Predictive values
As pointed out previously, sensitivity and specificity define the discriminative power of a diagnostic procedure (test) and give us the proportion of diseased and healthy individuals identified correctly by the test, respectively.
However, sensitivity and specificity tell us nothing about the predictive abilities of a positive or a negative result.
What a physician wants most from any diagnostic procedure is the answer to the following questions: In other words, if an individual presenting with stroke symptoms at the emergency department of our neurology clinic has an elevated value of S-100B protein (> 0.5 µg/L), and given the fact that a PPV for that marker is 69.2 %, the physician knows that there is a 69.2 % probability that this person has a stroke. For instance, PPV and NPV obtained in some primary care health institution will differ greatly from a tertiary care university hospital, where disease prevalence may be much higher than in the primary care setting.
That is the reason why some markers, like BNP, perform better in tertiary care institutions than in primary care.
Likelihood ratio
Likelihood ratio (LR) is the ratio of two probabilities: (i) probability that a given test result may be expected in a diseased individual and (ii) probability that the same result will occur in a healthy subject.
Likelihood ratio of a positive test (LR+) result is the ratio of the probability that a positive test result is expected in a diseased individual to the probability that a positive result occurs in a healthy subject. (LR+) = sensitivity / (1 -specificity)
Likelihood ratio of a negative test result (LR-) is the ratio of the probability that a negative test result may be expected in a diseased individual to the probability that a negative result may occur in a healthy subject.
It tells us how many times less likely it is to observe a negative test result in a diseased than in a healthy individual. (LR-) may be calculated according to the formula:
The advantage of likelihood ratios over predictive values is that they are not affected by the changes of the prevalence of the disease and can therefore be used to adopt the results from other investigators to your own patient population.
Moreover, likelihood ratios are very useful measures of diagnostic accuracy, since they have a direct mathematical relationship with pre-and post-test probabilities, allowing us to revise the a priori probability of a disease in a patient by knowing the result of a diagnostic test and its likelihood ratio.
How to revise the a priori probability of a disease in a certain patient?
Pre-and post-test probabilities may be easily revised using a graphical tool called the Fagan nomogram (FIG.   1) . By using the Fagan nomogram we can estimate how much the result of a diagnostic test changes the probability that a patient has a disease.
To use the Fagan nomogram we need to provide the best estimate of the probability of the disease in an individual, prior to any testing. This probability is usually called the pre-test probability or a priori probability.
The pre-test probability relates to the prevalence of the disease and patient risk factors. We also need to know the result of the test and its likelihood ratio.
If we draw a line connecting the pre-test probability and the likelihood ratio and extend the line until it intersects with the post-test probability axis, then the point of intersection is the post-test probability.
Post-test probability is the updated probability of a disease assigned to a certain patient, using the information of the result of a diagnostic test. If a diagnostic test is of high diagnostic accuracy, it will provide enough information to either greatly increase or decrease the probability of a disease.
If a test has low diagnostic accuracy, it will add no value to the existing probability.
It is generally accepted that ( Assume that a 74-year-old hypertensive male subject presents to the emergency department with stroke symptoms. Based on the clinical examination the physician estimates a probability of stroke in that patient, prior to any testing, to be as high as 90 %.
An S-100B test is ordered and the result is positive. We draw a line connecting the pre-test probability (90 %) and the likelihood ratio (LR+ = 2.25) and then extend the line until it intersects with the post-test probability axis.
The estimated post-test probability is approximately 97 % (FIG. 2) . Since LR+ was low, there was no significant change in the probability. We may conclude that, due to its low diagnostic accuracy for stroke, S-100B was of no use in revising probabilities.
Assume now that the pre-test probability was much lower (60 %) and that S-100B has a (LR+) of 20, instead of 2.25. If we now draw a line connecting the pre-test probability (60 %) and the likelihood ratio (LR+ = 20) and extend the line until it intersects with the post-test probability axis, the estimated post-test probability will again be approximately 97 %.
But this time the change of the pre-test probability of 60 % to the post-test probability of 97 % was significant and we may conclude that S-100B was helpful in revising probabilities.
This was an example of how we can use the information of the result of a diagnostic test and knowledge about the diagnostic accuracy of the test (LR) to update the pre-test probability of a disease in a certain patient.
In the first case with a high probability of stroke, the test did not help much in updating the probability of stroke, since the pre-test probability was high anyway and the test had low added value.
However, in the second case with a lower probability of stroke and a test with better diagnostic accuracy, the updated post-test probability was much higher. The knowledge of the result of the test has significantly changed the estimated probability of a stroke.
To conclude, likelihood ratios are able to assess and combine the complex clinical data and information provided by a diagnostic procedure or a test. Likelihood ratios are highly useful statistics for summarizing diagnostic accuracy, which help clinicians to make important decisions about patient care. 
